Instrumented assessment of muscle overactivity and spasticity with dynamic polyelectromyographic and motion analysis for treatment planning

American Journal of Physical Medicine and Rehabilitation

Volumn 83, Issue 10 SUPPL., 2004, Pages

  Esquenazi, Alberto ^a,b,d   Mayer, Nathaniel H ^c  

^a Moss Rehab ^*  (United States)

^b Gait and Motion Analysis Laboratory   (United States)

^c Drucker Brain Injury Center   (United States)

^d MOSS REHABILITATION RESEARCH INSTITUTE   (United States)

Author keywords

Botulinum Toxin A; Gait; Spasticity; Upper Motor Neuron Syndrome

Indexed keywords

BOTULINUM TOXIN A; PHENOL;

ANAPHYLAXIS; CLONUS; CONFERENCE PAPER; DYSTONIA; ELBOW FLEXION; ELECTROMYOGRAPHY; FATIGUE; FLEXOR REFLEX; GAIT; HALLUX; HEADACHE; HIP DISEASE; HUMAN; INFANTILE SPASM; KNEE; LIMB DEFORMITY; MEDICAL ASSESSMENT; MOTION; MOTOR NEURON DISEASE; MUSCLE CONTRACTION; MUSCLE DISEASE; MUSCLE WEAKNESS; MYOTATIC REFLEX; NAUSEA; PATHOPHYSIOLOGY; PES EQUINOVARUS; PRACTICE GUIDELINE; SHOULDER; SPASTICITY; SYNKINESIS; THIGH; TREATMENT CONTRAINDICATION; TREATMENT PLANNING;

BOTULINUM TOXIN TYPE A; ELECTROMYOGRAPHY; EQUINUS DEFORMITY; GAIT; HUMANS; LOWER EXTREMITY; MOTOR NEURON DISEASE; MUSCLE SPASTICITY; NEUROMUSCULAR AGENTS; NEUROMUSCULAR BLOCKADE; NEUROMUSCULAR BLOCKING AGENTS; PHENOL; UPPER EXTREMITY;

EID: 4644285034     PISSN: 08949115     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.PHM.0000141127.63160.3E     Document Type: Conference Paper

References (16)

1. Mayer N, Esquenazi A: Muscle overactivity and movement dysfunction in the upper motoneuron syndrome. Phys Med Rehabil Clin N Am 2003;14:855-83
2. O'Dwyer N, Ada L, Neilson PD: Spasticity and muscle contracture following stroke. Brain 1996;119:1737-49
3. Lance JW: Symposium synopsis, in Feldman RG, Young RR, Koella WP (eds): Spasticity: Disordered Motor Control. Chicago, Yearbook Medical, 1980, pp 485-94
4. Okuma Y, Lee RG: Reciprocal inhibition in hemiplegia: Correlation with clinical features in recovery. Can J Neurol Sci 1996;23:15-23
5. Dewald JPA, Rymer WZ: Factors underlying abnormal posture and movement in spastic hemiparesis, in Thilmann AF, Burke DJ, Rymer WZ (eds): Spasticity: Mechanisms and Management. Berlin, Springer-Verlag, 1993, pp 123-38
6. Mayer NH, Esquenazi A, Childers MK: Common patterns of clinical motor dysfunction. Muscle Nerve 1997;20(suppl 6):S21-35
7. Mayer NH, Esquenazi A, Keenan MAE: Patterns of upper motoneuron dysfunction in the lower limb: Gait Disorders, in Ruzicka, Hallet, Jankovic (eds): Advances in Neurology. Philadelphia, Lippincott Williams and Wilkins, 2001, vol 87, pp 311-9
8. Rosenbaum DA: Human Motor Control. San Diego, Academic Press, 1991
9. Latash ML, Anson JG: What are "normal movements" in atypical populations? Brain Behav Sci 1996;19:55-106
10. Keenan MA, Mayer NH, Esquenazi A, et al: A neuroorthopedic approach to the management of common patterns of upper motor neuron dysfunction after brain injury. Neurorehabilitation 1999;12:119-43
11. Esquenazi A, Talaty M: Gait analysis, technology, and clinical applications, in Braddom R (ed): Physical Medicine and Rehabilitation, ed 2. Philadelphia, WB Saunders, 1999
12. Ochi F, Esquenazi A, Hirai B, et al: Temporal-spatial features of gait after traumatic brain injury. J Head Trauma Rehabil 1999;14:105-15
13. Brin MF: Botulinum toxin: Chemistry, pharmacology, toxicity, and immunology. Muscle Nerve 1997;20(suppl 6): S146-68
14. Brashear A, Gordon MF, Elovic E, et al: A double-blind, randomized, placebo-controlled study of botulinum toxin type A in the treatment of upper-limb spasticity following stroke. N Engl J Med 2002; 347:395-400
15. Simpson DM: Treatment of spasticity with botulinum toxin. Muscle Nerve 2000;23:447-9
16. Griffith ER, Mayer NH: Hypertonicity in movement disorders, in Rosenthal N, Griffither M, Bond MR, et al (eds): Rehabilitation of the Adult and Child with Traumatic Brain Injury, ed 2. Philadelphia, F. A. Davis, 1990